Last updated on September 2018

A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer


Brief description of study

This is an open label, non-randomized, Phase 1b/2a, dose escalation and dose confirmation study of ZEN003694 in combination with enzalutamide in patients with mCRPC.

Clinical Study Identifier: NCT02711956

Contact Investigators or Research Sites near you

Start Over

Zenith Study Team

Karmanos Cancer Institute
Farmington Hills, MI United States
7.6miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.